Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Florbetaben PET for Beta-Amyloid Detection in Down Syndrome
NCT00928304Phase 2Completed
- Sponsor
- Life Molecular Imaging
- Start
- Jun 2009
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of florbetaben in Down syndrome, sponsored by Life Molecular Imaging. Started Jun 2009; status: completed.
02
Drugs
florbetaben
03
Conditions
Down syndrome
Beyond the preview
Go deeper on NCT00928304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00928304.